Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 435

    1.

    A UK consensus on the management of the bladder in multiple sclerosis.

    Fowler CJ, Panicker JN, Drake M, Harris C, Harrison SC, Kirby M, Lucas M, Macleod N, Mangnall J, North A, Porter B, Reid S, Russell N, Watkiss K, Wells M.

    Postgrad Med J. 2009 Oct;85(1008):552-9.PMID: 19789195 [PubMed - in process]Related articles

    2.

    In the Human Urothelium and Suburothelium, Intradetrusor Botulinum Neurotoxin Type A Does Not Induce Apoptosis: Preliminary Results.

    Kessler TM, Khan S, Panicker JN, Elneil S, Brandner S, Fowler CJ, Roosen A.

    Eur Urol. 2009 Sep 11. [Epub ahead of print]PMID: 19765885 [PubMed - as supplied by publisher]Related articles

    3.

    Effect of nitric oxide donors on membrane tritium accumulation of endocannabinoids and related endogenous lipids.

    Thors L, Fowler CJ.

    Eur J Pharmacol. 2009 Oct 25;621(1-3):10-8. Epub 2009 Aug 26.PMID: 19715690 [PubMed - in process]Related articles

    4.

    A Refocus on the Bladder as the Originator of Storage Lower Urinary Tract Symptoms: A Systematic Review of the Latest Literature.

    Roosen A, Chapple CR, Dmochowski RR, Fowler CJ, Gratzke C, Roehrborn CG, Stief CG, Andersson KE.

    Eur Urol. 2009 Aug 4. [Epub ahead of print]PMID: 19683859 [PubMed - as supplied by publisher]Related articles

    5.

    Lower urinary tract symptoms following neurological illness may be influenced by multiple factors: Observations from a neurorehabilitation service in a developing country.

    Panicker JN, Menon L, Anandkumar A, Sundaram KR, Fowler CJ.

    Neurourol Urodyn. 2009 May 27. [Epub ahead of print]PMID: 19475575 [PubMed - as supplied by publisher]Related articles

    6.

    Cadherin-11 up-regulation in overactive bladder suburothelial myofibroblasts.

    Roosen A, Apostolidis A, Elneil S, Khan S, Panicker J, Brandner S, Fowler CJ, Kessler TM.

    J Urol. 2009 Jul;182(1):190-5. Epub 2009 May 17.PMID: 19450843 [PubMed - in process]Related articles

    7.

    A decade of functional brain imaging applied to bladder control.

    Fowler CJ, Griffiths DJ.

    Neurourol Urodyn. 2009 May 1. [Epub ahead of print]PMID: 19412958 [PubMed - as supplied by publisher]Related articles

    8.

    Complete Continence after Botulinum Neurotoxin Type A Injections for Refractory Idiopathic Detrusor Overactivity Incontinence: Patient-Reported Outcome at 4 Weeks.

    Khan S, Panicker J, Roosen A, Gonzales G, Elneil S, Dasgupta P, Fowler CJ, Kessler TM.

    Eur Urol. 2009 Apr 21. [Epub ahead of print]PMID: 19394133 [PubMed - as supplied by publisher]Related articles

    9.

    Clean intermittent self-catheterization after botulinum neurotoxin type A injections: short-term effect on quality of life.

    Kessler TM, Khan S, Panicker J, Roosen A, Elneil S, Fowler CJ.

    Obstet Gynecol. 2009 May;113(5):1046-51.PMID: 19384119 [PubMed - indexed for MEDLINE]Related articles

    10.

    A UK consensus on the management of the bladder in multiple sclerosis.

    Fowler CJ, Panicker JN, Drake M, Harris C, Harrison SC, Kirby M, Lucas M, Macleod N, Mangnall J, North A, Porter B, Reid S, Russell N, Watkiss K, Wells M.

    J Neurol Neurosurg Psychiatry. 2009 May;80(5):470-7. Review.PMID: 19372287 [PubMed - indexed for MEDLINE]Related articles

    11.

    Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?

    Roth B, Studer UE, Fowler CJ, Kessler TM.

    J Urol. 2009 May;181(5):2209-13. Epub 2009 Mar 17.PMID: 19296974 [PubMed - indexed for MEDLINE]Related articles

    12.

    Sexual dysfunction in multiple sclerosis.

    Kessler TM, Fowler CJ, Panicker JN.

    Expert Rev Neurother. 2009 Mar;9(3):341-50. Review.PMID: 19271943 [PubMed - indexed for MEDLINE]Related articles

    13.

    What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection.

    Khan S, Kessler TM, Apostolidis A, Kalsi V, Panicker J, Roosen A, Gonzales G, Haslam C, Elneil S, Fowler CJ, Dasgupta P.

    J Urol. 2009 Apr;181(4):1773-8. Epub 2009 Feb 23.PMID: 19233414 [PubMed - indexed for MEDLINE]Related articles

    14.

    The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors.

    Minkkilä A, Myllymäki MJ, Saario SM, Castillo-Melendez JA, Koskinen AM, Fowler CJ, Leppänen J, Nevalainen T.

    Eur J Med Chem. 2009 Jul;44(7):2994-3008. Epub 2009 Jan 20.PMID: 19232787 [PubMed - indexed for MEDLINE]Related articles

    15.

    The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1.

    Fowler CJ, Naidu PS, Lichtman A, Onnis V.

    Br J Pharmacol. 2009 Feb;156(3):412-9. Review.PMID: 19226258 [PubMed - indexed for MEDLINE]Related articles

    16.

    Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience.

    Fowler CJ, Dunn A, Hayes-Lattin B, Hansen K, Hansen L, Lanier K, Nelson V, Kovacsovics T, Leis J, Calandra G, Maziarz RT.

    Bone Marrow Transplant. 2009 Jun;43(12):909-17. Epub 2009 Feb 2.PMID: 19182831 [PubMed - indexed for MEDLINE]Related articles

    17.

    Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.

    Anand P, Whiteside G, Fowler CJ, Hohmann AG.

    Brain Res Rev. 2009 Apr;60(1):255-66. Epub 2008 Dec 25. Review.PMID: 19150370 [PubMed - indexed for MEDLINE]Related articles

    18.

    A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer.

    Chung SC, Hammarsten P, Josefsson A, Stattin P, Granfors T, Egevad L, Mancini G, Lutz B, Bergh A, Fowler CJ.

    Eur J Cancer. 2009 Jan;45(1):174-82. Epub 2008 Dec 4.PMID: 19056257 [PubMed - indexed for MEDLINE]Related articles

    19.

    Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.

    Roosen A, Datta SN, Chowdhury RA, Patel PM, Kalsi V, Elneil S, Dasgupta P, Kessler TM, Khan S, Panicker J, Fry CH, Brandner S, Fowler CJ, Apostolidis A.

    Eur Urol. 2009 Jun;55(6):1440-8. Epub 2008 Nov 18.PMID: 19054608 [PubMed - indexed for MEDLINE]Related articles

    20.

    Sacral neuromodulation for urinary retention.

    Kessler TM, Fowler CJ.

    Nat Clin Pract Urol. 2008 Dec;5(12):657-66. Epub 2008 Nov 11. Review.PMID: 19002127 [PubMed - indexed for MEDLINE]Related articles

    21.

    Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?

    Sahai A, Sangster P, Kalsi V, Khan MS, Fowler CJ, Dasgupta P.

    BJU Int. 2009 Mar;103(5):630-4. Epub 2008 Oct 16.PMID: 18990156 [PubMed - indexed for MEDLINE]Related articles

    22.

    Enhanced anion exchange for selective sulfate extraction: overcoming the Hofmeister bias.

    Fowler CJ, Haverlock TJ, Moyer BA, Shriver JA, Gross DE, Marquez M, Sessler JL, Hossain MA, Bowman-James K.

    J Am Chem Soc. 2008 Nov 5;130(44):14386-7. Epub 2008 Oct 9.PMID: 18841965 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report.

    Apostolidis A, Dasgupta P, Denys P, Elneil S, Fowler CJ, Giannantoni A, Karsenty G, Schulte-Baukloh H, Schurch B, Wyndaele JJ.

    Eur Urol. 2008 Sep 17. [Epub ahead of print]PMID: 18823697 [PubMed - as supplied by publisher]Related articles

    25.

    "The tools of the trade"--an overview of the pharmacology of the endocannabinoid system.

    Fowler CJ.

    Curr Pharm Des. 2008;14(23):2254-65. Review.PMID: 18781976 [PubMed - indexed for MEDLINE]Related articles

    26.

    Second consensus statement on the diagnosis of multiple system atrophy.

    Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Dürr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M.

    Neurology. 2008 Aug 26;71(9):670-6.PMID: 18725592 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake?

    Fowler CJ, Ghafouri N.

    Pharmacol Res. 2008 Jul;58(1):72-6. Epub 2008 Jul 15.PMID: 18675915 [PubMed - indexed for MEDLINE]Related articles

    28.

    Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids.

    Thors L, Belghiti M, Fowler CJ.

    Br J Pharmacol. 2008 Sep;155(2):244-52. Epub 2008 Jun 16.PMID: 18552875 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    The neural control of micturition.

    Fowler CJ, Griffiths D, de Groat WC.

    Nat Rev Neurosci. 2008 Jun;9(6):453-66. Review.PMID: 18490916 [PubMed - indexed for MEDLINE]Related articles

    30.

    Editorial comment on: Influence of nerve transsections and combined bladder filling on intravesical electrostimulation-induced bladder contraction in the rat.

    Fowler CJ.

    Eur Urol. 2009 Sep;56(3):533. Epub 2008 Apr 30. No abstract available. PMID: 18472210 [PubMed - in process]Related articles

    31.

    Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

    Chancellor MB, Fowler CJ, Apostolidis A, de Groat WC, Smith CP, Somogyi GT, Aoki KR.

    Nat Clin Pract Urol. 2008 Jun;5(6):319-28. Epub 2008 May 6. Review.PMID: 18461049 [PubMed - indexed for MEDLINE]Related articles

    32.

    Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.

    Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, Gonzales G, Datta SN, Ghazi-Noori S, Elneil S, Dasgupta P, Fowler CJ.

    Eur Urol. 2008 Jun;53(6):1245-53. Epub 2008 Mar 7.PMID: 18343564 [PubMed - indexed for MEDLINE]Related articles

    33.

    The use of botulinum neurotoxin type A (BoNTA) in urology.

    Apostolidis A, Fowler CJ.

    J Neural Transm. 2008;115(4):593-605. Epub 2008 Mar 6. Review.PMID: 18322639 [PubMed - indexed for MEDLINE]Related articles

    34.

    Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity.

    Kalsi V, Apostolidis A, Gonzales G, Elneil S, Dasgupta P, Fowler CJ.

    Eur Urol. 2008 Jul;54(1):181-7. Epub 2007 Dec 26.PMID: 18191323 [PubMed - indexed for MEDLINE]Related articles

    35.

    Sacral neurostimulation for urinary retention: 10-year experience from one UK centre.

    Datta SN, Chaliha C, Singh A, Gonzales G, Mishra VC, Kavia RB, Kitchen N, Fowler CJ, Elneil S.

    BJU Int. 2008 Jan;101(2):192-6. Epub 2007 Oct 26.PMID: 17970787 [PubMed - indexed for MEDLINE]Related articles

    36.

    The pharmacology of the cannabinoid system--a question of efficacy and selectivity.

    Fowler CJ.

    Mol Neurobiol. 2007 Aug;36(1):15-25. Epub 2007 Jul 7. Review.PMID: 17952646 [PubMed - indexed for MEDLINE]Related articles

    37.

    Botulinum injections for the treatment of bladder symptoms of multiple sclerosis.

    Kalsi V, Gonzales G, Popat R, Apostolidis A, Elneil S, Dasgupta P, Fowler CJ.

    Ann Neurol. 2007 Nov;62(5):452-7.PMID: 17890635 [PubMed - indexed for MEDLINE]Related articles

    38.

    Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study.

    van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, Lycklama á Nijholt AA, Siegel S, Jonas U, Fowler CJ, Fall M, Gajewski JB, Hassouna MM, Cappellano F, Elhilali MM, Milam DF, Das AK, Dijkema HE, van den Hombergh U.

    J Urol. 2007 Nov;178(5):2029-34. Epub 2007 Sep 17.PMID: 17869298 [PubMed - indexed for MEDLINE]Related articles

    39.

    Inflammation and inflammatory agents activate protein kinase C epsilon translocation and excite guinea-pig submucosal neurons.

    Poole DP, Matsuyama H, Nguyen TV, Eriksson EM, Fowler CJ, Furness JB.

    Gastroenterology. 2007 Oct;133(4):1229-39. Epub 2007 Jul 10.PMID: 17765238 [PubMed - indexed for MEDLINE]Related articles

    40.

    Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase.

    Cisneros JA, Vandevoorde S, Ortega-Gutiérrez S, Paris C, Fowler CJ, López-Rodríguez ML.

    J Med Chem. 2007 Oct 4;50(20):5012-23. Epub 2007 Sep 1.PMID: 17764163 [PubMed - indexed for MEDLINE]Related articles

    41.

    Octamethyl-octaundecylcyclo[8]pyrrole: a promising sulfate anion extractant.

    Eller LR, Stepień M, Fowler CJ, Lee JT, Sessler JL, Moyer BA.

    J Am Chem Soc. 2007 Sep 12;129(36):11020-1. Epub 2007 Aug 21. No abstract available. Erratum in: J Am Chem Soc. 2007 Nov 21;129(46):14523. PMID: 17711284 [PubMed]Related articlesFree article

    42.

    Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake.

    Thors L, Eriksson J, Fowler CJ.

    Br J Pharmacol. 2007 Nov;152(5):744-50. Epub 2007 Aug 6.PMID: 17676056 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action.

    Fowler CJ.

    Br J Pharmacol. 2007 Nov;152(5):594-601. Epub 2007 Jul 9. Review.PMID: 17618306 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system.

    Lenman A, Fowler CJ.

    Br J Pharmacol. 2007 Aug;151(8):1343-51. Epub 2007 Jun 25.PMID: 17592505 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Successful treatment with botulinum toxin A after failed augmentation ileocystoplasty.

    Apostolidis A, Popat R, Harper M, Fowler CJ, Dasgupta P.

    Nat Clin Pract Urol. 2007 May;4(5):280-4.PMID: 17483813 [PubMed - indexed for MEDLINE]Related articles

    46.

    Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.

    Holt S, Paylor B, Boldrup L, Alajakku K, Vandevoorde S, Sundström A, Cocco MT, Onnis V, Fowler CJ.

    Eur J Pharmacol. 2007 Jun 22;565(1-3):26-36. Epub 2007 Mar 7.PMID: 17397826 [PubMed - indexed for MEDLINE]Related articles

    47.

    Cerebral mechanisms and voiding function.

    DasGupta R, Kavia RB, Fowler CJ.

    BJU Int. 2007 Apr;99(4):731-4. Review.PMID: 17378838 [PubMed - indexed for MEDLINE]Related articles

    49.

    The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.

    Thors L, Alajakku K, Fowler CJ.

    Br J Pharmacol. 2007 Apr;150(7):951-60. Epub 2007 Feb 26.PMID: 17325653 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Sexual function in men and women with neurological disorders.

    Rees PM, Fowler CJ, Maas CP.

    Lancet. 2007 Feb 10;369(9560):512-25. Review.PMID: 17292771 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...